Table2.
Papers evaluating miRNA changes to differentiate healthy donors (HD) from MGUS and MM. Those in bold have been replicated in different studies.
| Author | MiRNA increased | MiRNA decreased | Comment |
| Besse 82 | MiR-130a | Elevated in patients with extra-medullary disease over MM | |
| Navarro 83 | - | MiR-16, miR-17, miR-19b, miR-20a, miR-660 | MiRNA levels increased in patients achieving CR but did not reach healthy normal |
| Wang 84 | - | Let7a, let7b, let7i, miR-15a, miR-15b, miR-16, miR-20a, miR-21, miR-106b, miR-223, miR-361 | 4 of 11 reduced in MGUS,8 of 11 reduced in SMM, 11 of 11 reduced in MM - suggests progressive 'accumulation' of miRNA dysregulation with progressive disease |
| Sevcikova 85 | MiR-142-5p, miR-660, miR-29a | ||
| Huang 86 | MiR-148a, miR-181a, miR20a, miR221, miR-99b | MiR20a finding conflicts with other groups | |
| Kubiczkova 87 | MiR-34a | Let7d, let7e, miR-130a, miR-744 | Combination of let7e and miR-744 provided best ROC characteristics to differentiate HD and either MGUS or MM |
| Jones 88 | MiR-720, miR-1246 | MiR-1308 | Different combinations of the three required to differentiate HD from MGUS or MM |
| Hao 89 | MiR-4254 | MiR-19a | Combination could distinguish HD or MM |
| Lionetti 90 | 42 upregulated | 41 downregulated | Differentiate MM & PCL |